Merus

MRUSNASDAQ
$55.71
2.374.44%
At Close: -
$55.71
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed

Merus (NASDAQ:MRUS) Stock Quotes, Forecast and News Summary

Merus Stock (NASDAQ: MRUS) stock price, news, charts, stock research, profile.

Open$54.09
Close$55.71
Volume / Avg.632.89K / 1.03M
Day Range53.89 - 56.93
52 Wk Range19.81 - 61.61
Market Cap$3.75B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
54
Short Interest
10.22%
Days to Cover5.58
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Feb
0
0
0
0
Mar
0
0
0
0
Apr
0
0
0
0
May
1
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About
Sector
Healthcare
Industry
N/A
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. ...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
MRUS

FAQ

Q

How do I buy Merus (MRUS) stock?

A

You can purchase shares of Merus (NASDAQ:MRUS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Merus (MRUS) competitors?

A

There are no as such competitors for Merus.

Q

What is the target price for Merus (MRUS) stock?

A

There is no analysis for Merus.

Q

What is the forecast for Merus (MRUS) stock?

A

Merus has a consensus price target of $64.25.

Q

Current stock price for Merus (MRUS)?

A

The stock price for Merus (NASDAQ: MRUS) is $55.71 last updated Today at July 8, 2024 at 4:00 PM EDT.

Q

Does Merus (MRUS) pay a dividend?

A

There are no upcoming dividends for Merus.

Q

When is Merus (NASDAQ:MRUS) reporting earnings?

A

Merus’s Q2 earnings are confirmed for Monday, August 5, 2024.

Q

Is Merus (MRUS) going to split?

A

There is no upcoming split for Merus.

Q

What sector and industry does Merus (MRUS) operate in?

A

Merus is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.